Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Common Equity (2016 - 2025)

National Research's Common Equity history spans 16 years, with the latest figure at $14.0 million for Q4 2025.

  • For Q4 2025, Common Equity fell 55.28% year-over-year to $14.0 million; the TTM value through Dec 2025 reached $14.0 million, down 55.28%, while the annual FY2025 figure was $14.0 million, 55.28% down from the prior year.
  • Common Equity for Q4 2025 was $14.0 million at National Research, down from $14.3 million in the prior quarter.
  • Across five years, Common Equity topped out at $85.3 million in Q4 2021 and bottomed at $14.0 million in Q4 2025.
  • The 5-year median for Common Equity is $62.8 million (2022), against an average of $54.5 million.
  • The largest annual shift saw Common Equity skyrocketed 96.4% in 2021 before it crashed 58.66% in 2025.
  • A 5-year view of Common Equity shows it stood at $85.3 million in 2021, then dropped by 15.59% to $72.0 million in 2022, then tumbled by 32.04% to $49.0 million in 2023, then plummeted by 36.1% to $31.3 million in 2024, then tumbled by 55.28% to $14.0 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Common Equity are $14.0 million (Q4 2025), $14.3 million (Q3 2025), and $21.3 million (Q2 2025).